Literature DB >> 23440555

Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease.

Tomoyuki Kawada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23440555     DOI: 10.1007/s00535-013-0768-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  5 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test.

Authors:  Sergio Martinez-Hervas; Carlos Argente; Javier Garcia-Jodar; Antonia Priego; Jose T Real; Arturo Carratala; Rafael Carmena; Juan F Ascaso
Journal:  Metabolism       Date:  2010-09-17       Impact factor: 8.694

3.  Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis.

Authors:  Tomoyuki Kawada
Journal:  Metabolism       Date:  2009-12-30       Impact factor: 8.694

4.  Comparative evaluation of simple indices of insulin resistance.

Authors:  Olga Vaccaro; Maria Masulli; Vincenzo Cuomo; Angela Albarosa Rivellese; Matti Uusitupa; Bengt Vessby; Kjeld Hermansen; Linda Tapsell; Gabriele Riccardi
Journal:  Metabolism       Date:  2004-12       Impact factor: 8.694

5.  The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Authors:  A Campanati; G Ganzetti; A Di Sario; A Damiani; L Sandroni; L Rosa; A Benedetti; A Offidani
Journal:  J Gastroenterol       Date:  2012-10-13       Impact factor: 7.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.